This is related to the characteristic histologic heterogeneity of breast tumors; due to a higher incidence rate of metastasis, basal-like, and HER2-positive BC having a worse prognosis than tumors that express the estrogen receptor [26]. This evidence concerns the gene ESR1 and breast neoplasm.